Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00049998 · COMPLETED

Trial details

NCT number: NCT00049998
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small-Cell Lung Cancer

Start date: 2001-10-01
Primary completion: 2004-04-01
Enrollment: 760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.